Tubulointerstitial disease in diabetic nephropathy. - Wikidata - wikimedia - TriplyDB

Tubulointerstitial disease in diabetic nephropathy.

Tubulointerstitial disease in diabetic nephropathy.

http://www.wikidata.org/entity/Q37669397

about

Biomarkers of Renal Disease and Progression in Patients with Diabetes Elevated levels of miR-155 in blood and urine from patients with nephrolithiasis.Sulodexide Protects Renal Tubular Epithelial Cells from Oxidative Stress-Induced Injury via Upregulating Klotho Expression at an Early Stage of Diabetic Kidney Disease Diabetic Nephropathy: a Tangled Web to Unweave.Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose-induced oxidative stress in type 1 diabetic mice Resveratrol prevents renal lipotoxicity in high-fat diet-treated mouse model through regulating PPAR-α pathway.Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes.Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells.Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function.Protective effects of leflunomide on renal lesions in a rat model if diabetic nephropathy.Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease.

P2860

Q26799505-D6BAFDA5-1BDC-4908-8C09-4ED87DC22FAE Q34114226-A84F4167-32D1-4B5E-811A-C04509CA1279 Q41449615-26910E58-98FE-4140-9C0A-F5FBEF031545 Q41993558-C4AD9412-C88A-41A8-938B-E9B3B6AB0C9C Q42329981-CF9B3FAF-11D7-4C32-B7F5-1CF285895788 Q42700481-B318B466-0FB5-44A5-8F31-3566A3868BCC Q42876331-4444210D-B665-4AB2-8115-47B036E76AEB Q46419349-E423452B-D789-4A06-A362-1A797C9CCCE3 Q52680882-49BE462A-CADD-40FB-B15F-818DF07E00B5 Q53296448-755CCC02-0C07-4672-AA90-46911E1646F5 Q55278241-CB81BA04-9042-4674-A1D7-8D530AD0893B

P2860

Tubulointerstitial disease in diabetic nephropathy.

http://www.wikidata.org/entity/Q37669397

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tubulointerstitial disease in diabetic nephropathy.

@en

Tubulointerstitial disease in diabetic nephropathy.

@nl

type

label

Tubulointerstitial disease in diabetic nephropathy.

@en

Tubulointerstitial disease in diabetic nephropathy.

@nl

prefLabel

Tubulointerstitial disease in diabetic nephropathy.

@en

Tubulointerstitial disease in diabetic nephropathy.

@nl

P1433

Q37669397-481CA268-E910-4A51-A03C-708978CD876E

P1476

Q37669397-BD91B941-A45E-46E3-923A-715EBCBD3CBD

P2093

Q37669397-B9FB4F05-6C34-487E-A396-E9FF3F10782E

Q37669397-BCF24528-48DC-42EE-A882-E79156F15044

P2860

Q37669397-0413254C-231C-462C-9454-61DD4120CC78

Q37669397-05739D4F-95D3-45CF-9627-95EA25A57801

Q37669397-0590AD61-3793-42AE-B5EB-BE91321682DA

Q37669397-05E481D7-B293-43BF-99D5-DC7DA8541A0F

Q37669397-0978E03C-8798-4892-84CA-BCB9E3D374B2

Q37669397-0A3487BD-729C-48BD-9925-F631F56F0633

Q37669397-0AD8B044-221B-4C35-855D-711C7A0F9E23

Q37669397-0DF082CA-D0D7-4B1C-B720-36E5F2E1D2D7

Q37669397-0E790573-7006-4297-BB5D-EC4FA99102E5

Q37669397-119ABCE4-59C1-4A89-A644-E12F76447091

P304

Q37669397-39AF30E7-B00B-47C3-98B7-5A5564F02AEB

P31

Q37669397-FAE06B6D-16A1-4FB6-A18A-9534A5538BC8

P356

Q37669397-B1D8F2F4-A727-42DB-8753-DB71EC0CFAF0

P407

Q37669397-BDBE4EC9-9BEA-46CD-B17A-51F4F1E8F28D

P478

Q37669397-AA0E12D1-4446-4388-9508-C9F77289C965

P577

Q37669397-F2AE0B23-A38A-4AFF-B880-7A3311AF686B

P5875

Q37669397-1437E2AC-B841-403D-95CA-5C807C61B4D5

P698

Q37669397-5D3FE0F8-15CF-4235-A30E-6550EE2DCDDF

P932

Q37669397-D2804F70-F488-4444-ACB7-7D63BF19CA83

P356

P1433

International Journal of Nephrology and Renovascular Disease

P1476

Tubulointerstitial disease in diabetic nephropathy.

@en

P2093

Giancarlo Tonolo

http://www.w3.org/2001/XMLSchema#string

Sara Cherchi

http://www.w3.org/2001/XMLSchema#string

P2860

New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Biogenesis of small RNAs in animals

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension.

Mouse models of diabetic nephropathy.

Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes.

Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy.

P304

107-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJNRD.S37883

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261445295

http://www.w3.org/2001/XMLSchema#string

P698

24711709

http://www.w3.org/2001/XMLSchema#string

P932

3968088

http://www.w3.org/2001/XMLSchema#string